BackAimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Overview
Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 P/E Ratio

Latest P/E ratio for Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028: 178.74 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

178.74

P/E Ratio

178.74

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 (AFJKR) FAQ

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 posts a P/E ratio of 178.74. That is above the sector sector average of 24.91. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a P/E ratio near 24.91 is typical. Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's 178.74 is higher that level. That is roughly 617.5% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's P/E ratio of 178.74 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for AFJKR's P/E ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 24.91), and (3) consistency with growth and profitability. This page covers the first two; Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's other metric pages and overview cover the third.